Literature DB >> 26896038

Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.

Celia P Corona-Villalobos1, Lars L Sorensen2, Iraklis Pozios2, Linda Chu1, John Eng1, Maria Roselle Abraham2, Theodore P Abraham2, Ihab R Kamel1, Stefan L Zimmerman3.   

Abstract

We assessed whether cardiac MRI (CMR) and echocardiography (echo) have significant differences measuring left ventricular (LV) wall thickness (WT) in hypertrophic cardiomyopathy (HCM) as performed in the clinical routine. Retrospectively identified, clinically diagnosed HCM patients with interventricular-septal (IVS) pattern hypertrophy who underwent CMR and echo within the same day were included. Left Ventricular WT was measured by CMR in two planes and compared to both echo and contrast echo (cecho). 72 subjects, mean age 50.7 ± 16.2 years, 68 % males. Interventricular septal WT by echo and CMR planes showed good to excellent correlation. However, measurements of the postero-lateral wall showed poor correlation. Bland-Altman plots showed greater maximal IVS WT by echo compared to CMR measurement [SAX = 1.7 mm (-5.8, 9.3); LVOT = 1.1 mm (-5.6, 7.8)]. Differences were smaller between cecho and CMR [SAX = 0.8 mm (-9.2, 10.8); LVOT = -0.2 mm (-10.0, 9.6)]. Severity of WT by quartiles showed greater differences between echo and SAX CMR WT compared to cecho. Echocardiography typically measures greater WT than CMR, with the largest differences in moderate to severe hypertrophy. Contrast echocardiography more closely approximates CMR measurements of WT. These findings have potential clinical implications for risk stratification of subjects with HCM.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Echocardiography; Hypertrophic cardiomyopathy; Inter-study variability; Wall thickness

Mesh:

Year:  2016        PMID: 26896038     DOI: 10.1007/s10554-016-0858-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

Review 2.  Prevalence of hypertrophic cardiomyopathy and limitations of screening methods.

Authors:  L Fananapazir; N D Epstein
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

Review 3.  Hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron
Journal:  Lancet       Date:  2012-08-06       Impact factor: 79.321

Review 4.  Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.

Authors:  Nuno Cardim; Maurizio Galderisi; Thor Edvardsen; Sven Plein; Bogdan A Popescu; Antonello D'Andrea; Oliver Bruder; Bernard Cosyns; Laurent Davin; Erwan Donal; Antonio Freitas; Gilbert Habib; Anastasia Kitsiou; Steffen E Petersen; Stephen Schroeder; Patrizio Lancellotti; Paolo Camici; Raluca Dulgheru; Andreas Hagendorff; Massimo Lombardi; Denisa Muraru; Rosa Sicari
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-02-03       Impact factor: 6.875

5.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

6.  MRI of the cardiomyopathies.

Authors:  E Di Cesare
Journal:  Eur J Radiol       Date:  2001-06       Impact factor: 3.528

7.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Martin S Maron; Camillo Autore; John R Lesser; Luigi Rega; Giancarlo Casolo; Marcello De Santis; Giovanni Quarta; Stefano Nistri; Franco Cecchi; Carol J Salton; James E Udelson; Warren J Manning; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

8.  Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

Authors:  C R Cannan; G S Reeder; K R Bailey; L J Melton; B J Gersh
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

9.  Estimation of human myocardial mass with MR imaging.

Authors:  J Katz; M C Milliken; J Stray-Gundersen; L M Buja; R W Parkey; J H Mitchell; R M Peshock
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

10.  Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography. Identification by wide-angle two-dimensional echocardiography.

Authors:  B J Maron; J S Gottdiener; R O Bonow; S E Epstein
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

View more
  9 in total

Review 1.  Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.

Authors:  Waseem Hindieh; Raymond Chan; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

2.  Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.

Authors:  Daisuke Kamimura; Loretta R Cain; Robert J Mentz; Wendy B White; Michael J Blaha; Andrew P DeFilippis; Ervin R Fox; Carlos J Rodriguez; Rachel J Keith; Emelia J Benjamin; Javed Butler; Aruni Bhatnagar; Rose M Robertson; Michael D Winniford; Adolfo Correa; Michael E Hall
Journal:  Circulation       Date:  2018-04-16       Impact factor: 29.690

3.  Left Ventricular Mass and Wall Thickness Measurements Using Echocardiography and Cardiac MRI in Patients with Fabry Disease: Clinical Significance of Discrepant Findings.

Authors:  Ciara O'Brien; Ian Britton; Gauri R Karur; Robert M Iwanochko; Chantal F Morel; Elsie T Nguyen; Paaladinesh Thavendiranathan; Anna Woo; Kate Hanneman
Journal:  Radiol Cardiothorac Imaging       Date:  2020-06-11

4.  Left Ventricular Mid-Diastolic Wall Thickness: Normal Values for Coronary CT Angiography.

Authors:  Jeroen Walpot; Daniel Juneau; Samia Massalha; Girish Dwivedi; Frank J Rybicki; Benjamin J W Chow; João R Inácio
Journal:  Radiol Cardiothorac Imaging       Date:  2019-12-19

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 6.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

7.  Cardiovascular imaging 2016 in the International Journal of Cardiovascular Imaging.

Authors:  Johan H C Reiber; Johan De Sutter; Paul Schoenhagen; Arthur E Stillman; Nico R L Vande Veire
Journal:  Int J Cardiovasc Imaging       Date:  2017-06       Impact factor: 2.357

8.  Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy.

Authors:  Yamin Liu; Junaid Afzal; Styliani Vakrou; Gabriela V Greenland; C Conover Talbot; Virginia B Hebl; Yufan Guan; Rehan Karmali; Jil C Tardiff; Leslie A Leinwand; Jeffrey E Olgin; Samarjit Das; Ryuya Fukunaga; M Roselle Abraham
Journal:  Front Cardiovasc Med       Date:  2019-12-17

9.  Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Ewa Kowalik; Agata Kubik; Natalia Ojrzyńska-Witek; Joanna Petryka-Mazurkiewicz; Ewa Michalak; Łukasz Mazurkiewicz; Monika Gawor; Katarzyna Kożuch; Barbara Miłosz-Wieczorek; Jacek Grzybowski; Zofia Bilińska; Adam Witkowski; Anna Klisiewicz; Magdalena Marczak
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.